nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP2J2—Cholecalciferol—osteoporosis	0.324	0.397	CbGbCtD
Apixaban—ABCG2—Conjugated Estrogens—osteoporosis	0.0391	0.0478	CbGbCtD
Apixaban—ABCG2—Estradiol—osteoporosis	0.0343	0.042	CbGbCtD
Apixaban—CYP1A2—Estropipate—osteoporosis	0.0341	0.0417	CbGbCtD
Apixaban—CYP2C9—Estropipate—osteoporosis	0.0307	0.0375	CbGbCtD
Apixaban—CYP2C8—Raloxifene—osteoporosis	0.0294	0.0359	CbGbCtD
Apixaban—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0284	0.0347	CbGbCtD
Apixaban—CYP2C8—Cholecalciferol—osteoporosis	0.0227	0.0277	CbGbCtD
Apixaban—ABCB1—Ethinyl Estradiol—osteoporosis	0.0192	0.0235	CbGbCtD
Apixaban—CYP2C19—Cholecalciferol—osteoporosis	0.019	0.0233	CbGbCtD
Apixaban—CYP3A5—Estradiol—osteoporosis	0.019	0.0232	CbGbCtD
Apixaban—CYP2C8—Estradiol—osteoporosis	0.0183	0.0224	CbGbCtD
Apixaban—CYP3A4—Estropipate—osteoporosis	0.0179	0.0218	CbGbCtD
Apixaban—CYP3A4—Calcitriol—osteoporosis	0.0179	0.0218	CbGbCtD
Apixaban—CYP1A2—Conjugated Estrogens—osteoporosis	0.0161	0.0197	CbGbCtD
Apixaban—CYP2C9—Cholecalciferol—osteoporosis	0.0158	0.0193	CbGbCtD
Apixaban—CYP2C19—Estradiol—osteoporosis	0.0153	0.0188	CbGbCtD
Apixaban—CYP3A4—Ergocalciferol—osteoporosis	0.0143	0.0175	CbGbCtD
Apixaban—CYP1A2—Estradiol—osteoporosis	0.0141	0.0173	CbGbCtD
Apixaban—ABCB1—Conjugated Estrogens—osteoporosis	0.0141	0.0172	CbGbCtD
Apixaban—CYP2C9—Estradiol—osteoporosis	0.0127	0.0156	CbGbCtD
Apixaban—ABCB1—Estradiol—osteoporosis	0.0124	0.0151	CbGbCtD
Apixaban—CYP3A4—Raloxifene—osteoporosis	0.0119	0.0146	CbGbCtD
Apixaban—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0115	0.0141	CbGbCtD
Apixaban—CYP3A4—Cholecalciferol—osteoporosis	0.0092	0.0112	CbGbCtD
Apixaban—CYP3A4—Conjugated Estrogens—osteoporosis	0.00844	0.0103	CbGbCtD
Apixaban—CYP3A4—Estradiol—osteoporosis	0.00741	0.00907	CbGbCtD
Apixaban—Vaginal haemorrhage—Estropipate—osteoporosis	0.00177	0.0143	CcSEcCtD
Apixaban—Vaginal haemorrhage—Raloxifene—osteoporosis	0.00172	0.0139	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Ibandronate—osteoporosis	0.00153	0.0124	CcSEcCtD
Apixaban—Metrorrhagia—Ethinyl Estradiol—osteoporosis	0.00149	0.0121	CcSEcCtD
Apixaban—Menorrhagia—Ethinyl Estradiol—osteoporosis	0.00144	0.0116	CcSEcCtD
Apixaban—Melaena—Alendronate—osteoporosis	0.00126	0.0102	CcSEcCtD
Apixaban—Haematuria—Calcium Acetate—osteoporosis	0.00123	0.00997	CcSEcCtD
Apixaban—Metrorrhagia—Conjugated Estrogens—osteoporosis	0.00121	0.00982	CcSEcCtD
Apixaban—Contusion—Risedronate—osteoporosis	0.00119	0.00962	CcSEcCtD
Apixaban—Vaginal haemorrhage—Conjugated Estrogens—osteoporosis	0.00117	0.00948	CcSEcCtD
Apixaban—Ecchymosis—Ibandronate—osteoporosis	0.00114	0.00921	CcSEcCtD
Apixaban—Haematoma—Estradiol—osteoporosis	0.0011	0.00894	CcSEcCtD
Apixaban—Diabetes mellitus—Raloxifene—osteoporosis	0.00106	0.00859	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Calcitriol—osteoporosis	0.00103	0.00832	CcSEcCtD
Apixaban—Metrorrhagia—Estradiol—osteoporosis	0.00097	0.00786	CcSEcCtD
Apixaban—Ecchymosis—Risedronate—osteoporosis	0.000937	0.00759	CcSEcCtD
Apixaban—Haemoptysis—Estradiol—osteoporosis	0.000936	0.00759	CcSEcCtD
Apixaban—Vaginal haemorrhage—Estradiol—osteoporosis	0.000936	0.00759	CcSEcCtD
Apixaban—Menorrhagia—Estradiol—osteoporosis	0.000936	0.00759	CcSEcCtD
Apixaban—Syncope—Calcium Acetate—osteoporosis	0.000905	0.00733	CcSEcCtD
Apixaban—Loss of consciousness—Calcium Acetate—osteoporosis	0.000887	0.00718	CcSEcCtD
Apixaban—Breast disorder—Estropipate—osteoporosis	0.00086	0.00697	CcSEcCtD
Apixaban—Breast disorder—Raloxifene—osteoporosis	0.000833	0.00675	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Raloxifene—osteoporosis	0.00083	0.00672	CcSEcCtD
Apixaban—Breast disorder—Ibandronate—osteoporosis	0.000824	0.00668	CcSEcCtD
Apixaban—Anaemia—Ergocalciferol—osteoporosis	0.000824	0.00667	CcSEcCtD
Apixaban—Shock—Calcium Acetate—osteoporosis	0.00081	0.00656	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Calcitriol—osteoporosis	0.000804	0.00652	CcSEcCtD
Apixaban—Contusion—Estradiol—osteoporosis	0.000794	0.00644	CcSEcCtD
Apixaban—Hypotension—Calcium Acetate—osteoporosis	0.000769	0.00623	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.000715	0.00579	CcSEcCtD
Apixaban—Breast disorder—Ethinyl Estradiol—osteoporosis	0.000697	0.00565	CcSEcCtD
Apixaban—Liver function test abnormal—Risedronate—osteoporosis	0.000694	0.00563	CcSEcCtD
Apixaban—Hepatobiliary disease—Estropipate—osteoporosis	0.000693	0.00562	CcSEcCtD
Apixaban—Breast disorder—Risedronate—osteoporosis	0.000679	0.00551	CcSEcCtD
Apixaban—Hepatobiliary disease—Ibandronate—osteoporosis	0.000665	0.00539	CcSEcCtD
Apixaban—Liver function test abnormal—Pamidronate—osteoporosis	0.00066	0.00535	CcSEcCtD
Apixaban—Haemoglobin—Alendronate—osteoporosis	0.000652	0.00528	CcSEcCtD
Apixaban—Haemorrhage—Alendronate—osteoporosis	0.000648	0.00525	CcSEcCtD
Apixaban—Haemoglobin—Ibandronate—osteoporosis	0.000634	0.00514	CcSEcCtD
Apixaban—Haemorrhage—Ibandronate—osteoporosis	0.000631	0.00511	CcSEcCtD
Apixaban—Urinary tract disorder—Raloxifene—osteoporosis	0.00063	0.0051	CcSEcCtD
Apixaban—Connective tissue disorder—Raloxifene—osteoporosis	0.000627	0.00508	CcSEcCtD
Apixaban—Urethral disorder—Raloxifene—osteoporosis	0.000625	0.00506	CcSEcCtD
Apixaban—Urinary tract disorder—Ibandronate—osteoporosis	0.000623	0.00505	CcSEcCtD
Apixaban—Haemoglobin—Calcitriol—osteoporosis	0.000621	0.00503	CcSEcCtD
Apixaban—Connective tissue disorder—Ibandronate—osteoporosis	0.00062	0.00503	CcSEcCtD
Apixaban—Urethral disorder—Ibandronate—osteoporosis	0.000619	0.00501	CcSEcCtD
Apixaban—Haemorrhage—Calcitriol—osteoporosis	0.000618	0.00501	CcSEcCtD
Apixaban—Eye disorder—Estropipate—osteoporosis	0.000615	0.00498	CcSEcCtD
Apixaban—Anaemia—Etidronic acid—osteoporosis	0.000612	0.00496	CcSEcCtD
Apixaban—Hypersensitivity—Calcium Acetate—osteoporosis	0.000607	0.00492	CcSEcCtD
Apixaban—Angiopathy—Estropipate—osteoporosis	0.000597	0.00484	CcSEcCtD
Apixaban—Immune system disorder—Estropipate—osteoporosis	0.000595	0.00482	CcSEcCtD
Apixaban—Mediastinal disorder—Estropipate—osteoporosis	0.000593	0.00481	CcSEcCtD
Apixaban—Eye disorder—Ibandronate—osteoporosis	0.00059	0.00478	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Estradiol—osteoporosis	0.000578	0.00469	CcSEcCtD
Apixaban—Angiopathy—Raloxifene—osteoporosis	0.000578	0.00469	CcSEcCtD
Apixaban—Angiopathy—Ibandronate—osteoporosis	0.000573	0.00464	CcSEcCtD
Apixaban—Immune system disorder—Ibandronate—osteoporosis	0.00057	0.00462	CcSEcCtD
Apixaban—Mediastinal disorder—Ibandronate—osteoporosis	0.000569	0.00461	CcSEcCtD
Apixaban—Breast disorder—Conjugated Estrogens—osteoporosis	0.000568	0.0046	CcSEcCtD
Apixaban—Hepatobiliary disease—Risedronate—osteoporosis	0.000548	0.00444	CcSEcCtD
Apixaban—Dizziness—Calcium Acetate—osteoporosis	0.000544	0.00441	CcSEcCtD
Apixaban—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000536	0.00434	CcSEcCtD
Apixaban—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000534	0.00432	CcSEcCtD
Apixaban—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000527	0.00427	CcSEcCtD
Apixaban—Haematuria—Pamidronate—osteoporosis	0.000525	0.00426	CcSEcCtD
Apixaban—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.000524	0.00425	CcSEcCtD
Apixaban—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000523	0.00424	CcSEcCtD
Apixaban—Haemoglobin—Risedronate—osteoporosis	0.000523	0.00424	CcSEcCtD
Apixaban—Anaemia—Alendronate—osteoporosis	0.000522	0.00423	CcSEcCtD
Apixaban—Haemorrhage—Risedronate—osteoporosis	0.00052	0.00421	CcSEcCtD
Apixaban—Urinary tract disorder—Risedronate—osteoporosis	0.000514	0.00416	CcSEcCtD
Apixaban—Connective tissue disorder—Risedronate—osteoporosis	0.000511	0.00414	CcSEcCtD
Apixaban—Urethral disorder—Risedronate—osteoporosis	0.00051	0.00413	CcSEcCtD
Apixaban—Anaemia—Ibandronate—osteoporosis	0.000508	0.00412	CcSEcCtD
Apixaban—Eye disorder—Ethinyl Estradiol—osteoporosis	0.000499	0.00404	CcSEcCtD
Apixaban—Syncope—Raloxifene—osteoporosis	0.000498	0.00403	CcSEcCtD
Apixaban—Haemoglobin—Pamidronate—osteoporosis	0.000497	0.00403	CcSEcCtD
Apixaban—Haemorrhage—Pamidronate—osteoporosis	0.000494	0.00401	CcSEcCtD
Apixaban—Nausea—Calcium Acetate—osteoporosis	0.000489	0.00396	CcSEcCtD
Apixaban—Urinary tract disorder—Pamidronate—osteoporosis	0.000488	0.00396	CcSEcCtD
Apixaban—Loss of consciousness—Raloxifene—osteoporosis	0.000488	0.00395	CcSEcCtD
Apixaban—Eye disorder—Risedronate—osteoporosis	0.000486	0.00394	CcSEcCtD
Apixaban—Connective tissue disorder—Pamidronate—osteoporosis	0.000486	0.00394	CcSEcCtD
Apixaban—Urethral disorder—Pamidronate—osteoporosis	0.000485	0.00393	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000484	0.00393	CcSEcCtD
Apixaban—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000484	0.00392	CcSEcCtD
Apixaban—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000482	0.0039	CcSEcCtD
Apixaban—Haematuria—Zoledronate—osteoporosis	0.00048	0.00389	CcSEcCtD
Apixaban—Angiopathy—Risedronate—osteoporosis	0.000472	0.00382	CcSEcCtD
Apixaban—Immune system disorder—Risedronate—osteoporosis	0.00047	0.00381	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000469	0.0038	CcSEcCtD
Apixaban—Mediastinal disorder—Risedronate—osteoporosis	0.000469	0.0038	CcSEcCtD
Apixaban—Anaphylactic shock—Estropipate—osteoporosis	0.000468	0.00379	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000465	0.00376	CcSEcCtD
Apixaban—Liver function test abnormal—Estradiol—osteoporosis	0.000465	0.00376	CcSEcCtD
Apixaban—Eye disorder—Pamidronate—osteoporosis	0.000462	0.00374	CcSEcCtD
Apixaban—Nervous system disorder—Estropipate—osteoporosis	0.000459	0.00372	CcSEcCtD
Apixaban—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000458	0.00371	CcSEcCtD
Apixaban—Breast disorder—Estradiol—osteoporosis	0.000455	0.00368	CcSEcCtD
Apixaban—Skin disorder—Estropipate—osteoporosis	0.000454	0.00368	CcSEcCtD
Apixaban—Angiopathy—Pamidronate—osteoporosis	0.000449	0.00364	CcSEcCtD
Apixaban—Anaphylactic shock—Ibandronate—osteoporosis	0.000448	0.00363	CcSEcCtD
Apixaban—Immune system disorder—Pamidronate—osteoporosis	0.000447	0.00362	CcSEcCtD
Apixaban—Urinary tract disorder—Zoledronate—osteoporosis	0.000446	0.00361	CcSEcCtD
Apixaban—Mediastinal disorder—Pamidronate—osteoporosis	0.000446	0.00361	CcSEcCtD
Apixaban—Shock—Raloxifene—osteoporosis	0.000446	0.00361	CcSEcCtD
Apixaban—Nervous system disorder—Raloxifene—osteoporosis	0.000444	0.0036	CcSEcCtD
Apixaban—Connective tissue disorder—Zoledronate—osteoporosis	0.000444	0.0036	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000444	0.0036	CcSEcCtD
Apixaban—Thrombocytopenia—Raloxifene—osteoporosis	0.000444	0.00359	CcSEcCtD
Apixaban—Urethral disorder—Zoledronate—osteoporosis	0.000443	0.00359	CcSEcCtD
Apixaban—Shock—Ibandronate—osteoporosis	0.000441	0.00357	CcSEcCtD
Apixaban—Skin disorder—Raloxifene—osteoporosis	0.00044	0.00357	CcSEcCtD
Apixaban—Nervous system disorder—Ibandronate—osteoporosis	0.00044	0.00356	CcSEcCtD
Apixaban—Anaphylactic shock—Calcitriol—osteoporosis	0.000439	0.00356	CcSEcCtD
Apixaban—Skin disorder—Ibandronate—osteoporosis	0.000436	0.00353	CcSEcCtD
Apixaban—Nausea—Ergocalciferol—osteoporosis	0.000432	0.0035	CcSEcCtD
Apixaban—Skin disorder—Calcitriol—osteoporosis	0.000426	0.00345	CcSEcCtD
Apixaban—Eye disorder—Zoledronate—osteoporosis	0.000422	0.00342	CcSEcCtD
Apixaban—Anaemia—Risedronate—osteoporosis	0.000419	0.00339	CcSEcCtD
Apixaban—Angiopathy—Zoledronate—osteoporosis	0.00041	0.00332	CcSEcCtD
Apixaban—Immune system disorder—Zoledronate—osteoporosis	0.000408	0.00331	CcSEcCtD
Apixaban—Mediastinal disorder—Zoledronate—osteoporosis	0.000407	0.0033	CcSEcCtD
Apixaban—Eye disorder—Conjugated Estrogens—osteoporosis	0.000406	0.00329	CcSEcCtD
Apixaban—Syncope—Risedronate—osteoporosis	0.000406	0.00329	CcSEcCtD
Apixaban—Gastrointestinal disorder—Estropipate—osteoporosis	0.000404	0.00327	CcSEcCtD
Apixaban—Hypersensitivity—Etidronic acid—osteoporosis	0.000398	0.00323	CcSEcCtD
Apixaban—Loss of consciousness—Risedronate—osteoporosis	0.000398	0.00322	CcSEcCtD
Apixaban—Anaemia—Pamidronate—osteoporosis	0.000398	0.00322	CcSEcCtD
Apixaban—Angiopathy—Conjugated Estrogens—osteoporosis	0.000395	0.0032	CcSEcCtD
Apixaban—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000393	0.00318	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000393	0.00318	CcSEcCtD
Apixaban—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000392	0.00318	CcSEcCtD
Apixaban—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000391	0.00317	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000387	0.00314	CcSEcCtD
Apixaban—Syncope—Pamidronate—osteoporosis	0.000386	0.00313	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000383	0.0031	CcSEcCtD
Apixaban—Loss of consciousness—Pamidronate—osteoporosis	0.000378	0.00307	CcSEcCtD
Apixaban—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000372	0.00301	CcSEcCtD
Apixaban—Haematuria—Estradiol—osteoporosis	0.00037	0.003	CcSEcCtD
Apixaban—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000368	0.00298	CcSEcCtD
Apixaban—Hepatobiliary disease—Estradiol—osteoporosis	0.000367	0.00297	CcSEcCtD
Apixaban—Epistaxis—Estradiol—osteoporosis	0.000366	0.00296	CcSEcCtD
Apixaban—Shock—Risedronate—osteoporosis	0.000364	0.00295	CcSEcCtD
Apixaban—Anaemia—Zoledronate—osteoporosis	0.000363	0.00294	CcSEcCtD
Apixaban—Nervous system disorder—Risedronate—osteoporosis	0.000362	0.00294	CcSEcCtD
Apixaban—Skin disorder—Risedronate—osteoporosis	0.000359	0.00291	CcSEcCtD
Apixaban—Syncope—Zoledronate—osteoporosis	0.000353	0.00286	CcSEcCtD
Apixaban—Anaphylactic shock—Pamidronate—osteoporosis	0.000351	0.00285	CcSEcCtD
Apixaban—Haemoglobin—Estradiol—osteoporosis	0.00035	0.00283	CcSEcCtD
Apixaban—Haemorrhage—Estradiol—osteoporosis	0.000348	0.00282	CcSEcCtD
Apixaban—Shock—Pamidronate—osteoporosis	0.000346	0.0028	CcSEcCtD
Apixaban—Loss of consciousness—Zoledronate—osteoporosis	0.000346	0.0028	CcSEcCtD
Apixaban—Hypersensitivity—Estropipate—osteoporosis	0.000345	0.00279	CcSEcCtD
Apixaban—Nervous system disorder—Pamidronate—osteoporosis	0.000345	0.00279	CcSEcCtD
Apixaban—Thrombocytopenia—Pamidronate—osteoporosis	0.000344	0.00279	CcSEcCtD
Apixaban—Urinary tract disorder—Estradiol—osteoporosis	0.000344	0.00279	CcSEcCtD
Apixaban—Connective tissue disorder—Estradiol—osteoporosis	0.000342	0.00277	CcSEcCtD
Apixaban—Urethral disorder—Estradiol—osteoporosis	0.000341	0.00276	CcSEcCtD
Apixaban—Rash—Etidronic acid—osteoporosis	0.000341	0.00276	CcSEcCtD
Apixaban—Dermatitis—Etidronic acid—osteoporosis	0.000341	0.00276	CcSEcCtD
Apixaban—Syncope—Conjugated Estrogens—osteoporosis	0.00034	0.00275	CcSEcCtD
Apixaban—Hypersensitivity—Alendronate—osteoporosis	0.000339	0.00275	CcSEcCtD
Apixaban—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000333	0.0027	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000332	0.00269	CcSEcCtD
Apixaban—Hypersensitivity—Ibandronate—osteoporosis	0.00033	0.00268	CcSEcCtD
Apixaban—Hypotension—Pamidronate—osteoporosis	0.000328	0.00266	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000327	0.00265	CcSEcCtD
Apixaban—Eye disorder—Estradiol—osteoporosis	0.000325	0.00264	CcSEcCtD
Apixaban—Hypersensitivity—Calcitriol—osteoporosis	0.000323	0.00262	CcSEcCtD
Apixaban—Nausea—Etidronic acid—osteoporosis	0.000321	0.0026	CcSEcCtD
Apixaban—Anaphylactic shock—Zoledronate—osteoporosis	0.000321	0.0026	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00032	0.00259	CcSEcCtD
Apixaban—Gastrointestinal disorder—Risedronate—osteoporosis	0.000319	0.00259	CcSEcCtD
Apixaban—Angiopathy—Estradiol—osteoporosis	0.000316	0.00256	CcSEcCtD
Apixaban—Shock—Zoledronate—osteoporosis	0.000316	0.00256	CcSEcCtD
Apixaban—Nervous system disorder—Zoledronate—osteoporosis	0.000315	0.00255	CcSEcCtD
Apixaban—Immune system disorder—Estradiol—osteoporosis	0.000314	0.00255	CcSEcCtD
Apixaban—Thrombocytopenia—Zoledronate—osteoporosis	0.000314	0.00255	CcSEcCtD
Apixaban—Mediastinal disorder—Estradiol—osteoporosis	0.000314	0.00254	CcSEcCtD
Apixaban—Skin disorder—Zoledronate—osteoporosis	0.000312	0.00253	CcSEcCtD
Apixaban—Dizziness—Estropipate—osteoporosis	0.000309	0.00251	CcSEcCtD
Apixaban—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000309	0.0025	CcSEcCtD
Apixaban—Dizziness—Alendronate—osteoporosis	0.000305	0.00247	CcSEcCtD
Apixaban—Shock—Conjugated Estrogens—osteoporosis	0.000304	0.00246	CcSEcCtD
Apixaban—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000303	0.00246	CcSEcCtD
Apixaban—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000303	0.00246	CcSEcCtD
Apixaban—Skin disorder—Conjugated Estrogens—osteoporosis	0.0003	0.00243	CcSEcCtD
Apixaban—Hypotension—Zoledronate—osteoporosis	0.0003	0.00243	CcSEcCtD
Apixaban—Dizziness—Raloxifene—osteoporosis	0.0003	0.00243	CcSEcCtD
Apixaban—Dizziness—Ibandronate—osteoporosis	0.000297	0.0024	CcSEcCtD
Apixaban—Rash—Estropipate—osteoporosis	0.000295	0.00239	CcSEcCtD
Apixaban—Dermatitis—Estropipate—osteoporosis	0.000295	0.00239	CcSEcCtD
Apixaban—Rash—Alendronate—osteoporosis	0.00029	0.00235	CcSEcCtD
Apixaban—Dermatitis—Alendronate—osteoporosis	0.00029	0.00235	CcSEcCtD
Apixaban—Hypotension—Conjugated Estrogens—osteoporosis	0.000289	0.00234	CcSEcCtD
Apixaban—Rash—Raloxifene—osteoporosis	0.000286	0.00231	CcSEcCtD
Apixaban—Dermatitis—Raloxifene—osteoporosis	0.000285	0.00231	CcSEcCtD
Apixaban—Rash—Ibandronate—osteoporosis	0.000283	0.00229	CcSEcCtD
Apixaban—Dermatitis—Ibandronate—osteoporosis	0.000282	0.00229	CcSEcCtD
Apixaban—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000279	0.00226	CcSEcCtD
Apixaban—Nausea—Estropipate—osteoporosis	0.000278	0.00225	CcSEcCtD
Apixaban—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000277	0.00224	CcSEcCtD
Apixaban—Rash—Calcitriol—osteoporosis	0.000277	0.00224	CcSEcCtD
Apixaban—Dermatitis—Calcitriol—osteoporosis	0.000277	0.00224	CcSEcCtD
Apixaban—Nausea—Alendronate—osteoporosis	0.000274	0.00222	CcSEcCtD
Apixaban—Hypersensitivity—Risedronate—osteoporosis	0.000272	0.00221	CcSEcCtD
Apixaban—Syncope—Estradiol—osteoporosis	0.000272	0.0022	CcSEcCtD
Apixaban—Nausea—Raloxifene—osteoporosis	0.000269	0.00218	CcSEcCtD
Apixaban—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000267	0.00216	CcSEcCtD
Apixaban—Nausea—Ibandronate—osteoporosis	0.000266	0.00216	CcSEcCtD
Apixaban—Loss of consciousness—Estradiol—osteoporosis	0.000266	0.00216	CcSEcCtD
Apixaban—Nausea—Calcitriol—osteoporosis	0.000261	0.00211	CcSEcCtD
Apixaban—Hypersensitivity—Pamidronate—osteoporosis	0.000259	0.0021	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000256	0.00208	CcSEcCtD
Apixaban—Dizziness—Ethinyl Estradiol—osteoporosis	0.000251	0.00203	CcSEcCtD
Apixaban—Anaphylactic shock—Estradiol—osteoporosis	0.000247	0.002	CcSEcCtD
Apixaban—Dizziness—Risedronate—osteoporosis	0.000244	0.00198	CcSEcCtD
Apixaban—Shock—Estradiol—osteoporosis	0.000243	0.00197	CcSEcCtD
Apixaban—Nervous system disorder—Estradiol—osteoporosis	0.000243	0.00197	CcSEcCtD
Apixaban—Skin disorder—Estradiol—osteoporosis	0.00024	0.00195	CcSEcCtD
Apixaban—Rash—Ethinyl Estradiol—osteoporosis	0.000239	0.00194	CcSEcCtD
Apixaban—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000239	0.00193	CcSEcCtD
Apixaban—Hypersensitivity—Zoledronate—osteoporosis	0.000236	0.00192	CcSEcCtD
Apixaban—Rash—Risedronate—osteoporosis	0.000233	0.00189	CcSEcCtD
Apixaban—Dermatitis—Risedronate—osteoporosis	0.000233	0.00189	CcSEcCtD
Apixaban—Dizziness—Pamidronate—osteoporosis	0.000232	0.00188	CcSEcCtD
Apixaban—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000228	0.00184	CcSEcCtD
Apixaban—Nausea—Ethinyl Estradiol—osteoporosis	0.000225	0.00182	CcSEcCtD
Apixaban—Rash—Pamidronate—osteoporosis	0.000222	0.00179	CcSEcCtD
Apixaban—Dermatitis—Pamidronate—osteoporosis	0.000221	0.00179	CcSEcCtD
Apixaban—Nausea—Risedronate—osteoporosis	0.00022	0.00178	CcSEcCtD
Apixaban—Gastrointestinal disorder—Estradiol—osteoporosis	0.000214	0.00173	CcSEcCtD
Apixaban—Dizziness—Zoledronate—osteoporosis	0.000212	0.00172	CcSEcCtD
Apixaban—Nausea—Pamidronate—osteoporosis	0.000209	0.00169	CcSEcCtD
Apixaban—Dizziness—Conjugated Estrogens—osteoporosis	0.000204	0.00166	CcSEcCtD
Apixaban—Rash—Zoledronate—osteoporosis	0.000202	0.00164	CcSEcCtD
Apixaban—Dermatitis—Zoledronate—osteoporosis	0.000202	0.00164	CcSEcCtD
Apixaban—Rash—Conjugated Estrogens—osteoporosis	0.000195	0.00158	CcSEcCtD
Apixaban—Dermatitis—Conjugated Estrogens—osteoporosis	0.000195	0.00158	CcSEcCtD
Apixaban—Nausea—Zoledronate—osteoporosis	0.000191	0.00154	CcSEcCtD
Apixaban—Nausea—Conjugated Estrogens—osteoporosis	0.000184	0.00149	CcSEcCtD
Apixaban—Hypersensitivity—Estradiol—osteoporosis	0.000182	0.00148	CcSEcCtD
Apixaban—Dizziness—Estradiol—osteoporosis	0.000164	0.00133	CcSEcCtD
Apixaban—Rash—Estradiol—osteoporosis	0.000156	0.00126	CcSEcCtD
Apixaban—Dermatitis—Estradiol—osteoporosis	0.000156	0.00126	CcSEcCtD
Apixaban—Nausea—Estradiol—osteoporosis	0.000147	0.00119	CcSEcCtD
Apixaban—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	5.81e-05	0.000986	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—POMC—osteoporosis	5.79e-05	0.000983	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	5.73e-05	0.000973	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PNP—osteoporosis	5.65e-05	0.00096	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ATIC—osteoporosis	5.65e-05	0.00096	CbGpPWpGaD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.62e-05	0.000953	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—IGF1—osteoporosis	5.57e-05	0.000946	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.45e-05	0.000925	CbGpPWpGaD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.35e-05	0.000908	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.31e-05	0.000902	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.22e-05	0.000886	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL1B—osteoporosis	5.17e-05	0.000877	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	4.96e-05	0.000843	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	4.95e-05	0.000841	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—POMC—osteoporosis	4.95e-05	0.000841	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.95e-05	0.000839	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	4.94e-05	0.000839	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	4.9e-05	0.000831	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP19A1—osteoporosis	4.89e-05	0.00083	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CA2—osteoporosis	4.81e-05	0.000816	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—OXCT1—osteoporosis	4.81e-05	0.000816	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MGLL—osteoporosis	4.68e-05	0.000795	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PKM—osteoporosis	4.67e-05	0.000793	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—FDPS—osteoporosis	4.67e-05	0.000793	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.66e-05	0.000791	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.66e-05	0.000791	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	4.61e-05	0.000783	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	4.61e-05	0.000783	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.54e-05	0.000771	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.44e-05	0.000753	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PGLS—osteoporosis	4.43e-05	0.000752	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPD2—osteoporosis	4.43e-05	0.000752	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.33e-05	0.000736	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—POMC—osteoporosis	4.29e-05	0.000728	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.25e-05	0.000721	CbGpPWpGaD
Apixaban—F10—Hemostasis—TGFB1—osteoporosis	4.25e-05	0.000721	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ATIC—osteoporosis	4.05e-05	0.000687	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PNP—osteoporosis	4.05e-05	0.000687	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PKM—osteoporosis	4.05e-05	0.000687	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—FDPS—osteoporosis	4.05e-05	0.000687	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.02e-05	0.000682	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ADCY5—osteoporosis	4e-05	0.000678	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—IDH2—osteoporosis	3.98e-05	0.000676	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GPX1—osteoporosis	3.98e-05	0.000676	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.96e-05	0.000672	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPD2—osteoporosis	3.84e-05	0.000651	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PGLS—osteoporosis	3.84e-05	0.000651	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.83e-05	0.00065	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—POMC—osteoporosis	3.83e-05	0.00065	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.82e-05	0.000648	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.78e-05	0.000641	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TNF—osteoporosis	3.75e-05	0.000637	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP27A1—osteoporosis	3.74e-05	0.000636	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—MTHFR—osteoporosis	3.67e-05	0.000624	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ACP5—osteoporosis	3.64e-05	0.000618	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.63e-05	0.000616	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PKM—osteoporosis	3.61e-05	0.000613	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—FDPS—osteoporosis	3.61e-05	0.000613	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.61e-05	0.000613	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PKM—osteoporosis	3.52e-05	0.000598	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—FDPS—osteoporosis	3.52e-05	0.000598	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PNP—osteoporosis	3.51e-05	0.000595	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ATIC—osteoporosis	3.51e-05	0.000595	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—POMC—osteoporosis	3.49e-05	0.000593	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CA2—osteoporosis	3.44e-05	0.000585	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—OXCT1—osteoporosis	3.44e-05	0.000585	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.43e-05	0.000582	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PGLS—osteoporosis	3.42e-05	0.000581	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPD2—osteoporosis	3.42e-05	0.000581	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TPI1—osteoporosis	3.39e-05	0.000575	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MGLL—osteoporosis	3.36e-05	0.00057	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PGLS—osteoporosis	3.34e-05	0.000567	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPD2—osteoporosis	3.34e-05	0.000567	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.31e-05	0.000561	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PKM—osteoporosis	3.29e-05	0.000559	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FDPS—osteoporosis	3.29e-05	0.000559	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—P4HB—osteoporosis	3.18e-05	0.00054	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ATIC—osteoporosis	3.13e-05	0.000532	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PNP—osteoporosis	3.13e-05	0.000532	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GAPDH—osteoporosis	3.13e-05	0.00053	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPD2—osteoporosis	3.12e-05	0.00053	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PGLS—osteoporosis	3.12e-05	0.00053	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.09e-05	0.000524	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ATIC—osteoporosis	3.06e-05	0.000519	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PNP—osteoporosis	3.06e-05	0.000519	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—RAP1A—osteoporosis	3.04e-05	0.000517	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—POMC—osteoporosis	2.98e-05	0.000506	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CA2—osteoporosis	2.98e-05	0.000506	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—OXCT1—osteoporosis	2.98e-05	0.000506	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—POMC—osteoporosis	2.94e-05	0.000499	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MGLL—osteoporosis	2.91e-05	0.000493	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ATIC—osteoporosis	2.85e-05	0.000485	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PNP—osteoporosis	2.85e-05	0.000485	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—IDH2—osteoporosis	2.85e-05	0.000484	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FDPS—osteoporosis	2.81e-05	0.000478	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PKM—osteoporosis	2.81e-05	0.000478	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.74e-05	0.000465	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.68e-05	0.000455	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PGLS—osteoporosis	2.67e-05	0.000453	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPD2—osteoporosis	2.67e-05	0.000453	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—OXCT1—osteoporosis	2.66e-05	0.000452	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA2—osteoporosis	2.66e-05	0.000452	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ACP5—osteoporosis	2.61e-05	0.000443	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—OXCT1—osteoporosis	2.6e-05	0.000441	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA2—osteoporosis	2.6e-05	0.000441	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MGLL—osteoporosis	2.59e-05	0.00044	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MGLL—osteoporosis	2.53e-05	0.00043	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—IDH2—osteoporosis	2.47e-05	0.00042	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ENO1—osteoporosis	2.46e-05	0.000418	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.45e-05	0.000415	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ATIC—osteoporosis	2.44e-05	0.000414	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PNP—osteoporosis	2.44e-05	0.000414	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—OXCT1—osteoporosis	2.43e-05	0.000412	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA2—osteoporosis	2.43e-05	0.000412	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TPI1—osteoporosis	2.43e-05	0.000412	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PSMA2—osteoporosis	2.42e-05	0.000412	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PSMA5—osteoporosis	2.42e-05	0.000412	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MGLL—osteoporosis	2.37e-05	0.000402	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.32e-05	0.000394	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—POMC—osteoporosis	2.3e-05	0.000391	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—P4HB—osteoporosis	2.28e-05	0.000387	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ACP5—osteoporosis	2.26e-05	0.000384	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GAPDH—osteoporosis	2.24e-05	0.00038	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.23e-05	0.000379	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.23e-05	0.000379	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—IDH2—osteoporosis	2.21e-05	0.000374	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—RAP1A—osteoporosis	2.18e-05	0.00037	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PKM—osteoporosis	2.17e-05	0.000369	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FDPS—osteoporosis	2.17e-05	0.000369	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—IDH2—osteoporosis	2.15e-05	0.000366	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TPI1—osteoporosis	2.1e-05	0.000357	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—OXCT1—osteoporosis	2.07e-05	0.000352	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA2—osteoporosis	2.07e-05	0.000352	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.07e-05	0.000352	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PGLS—osteoporosis	2.06e-05	0.000349	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPD2—osteoporosis	2.06e-05	0.000349	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP27A1—osteoporosis	2.02e-05	0.000344	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MGLL—osteoporosis	2.02e-05	0.000343	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ACP5—osteoporosis	2.02e-05	0.000342	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—IDH2—osteoporosis	2.01e-05	0.000341	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.99e-05	0.000338	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.99e-05	0.000337	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.98e-05	0.000336	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—P4HB—osteoporosis	1.98e-05	0.000335	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ACP5—osteoporosis	1.97e-05	0.000334	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP19A1—osteoporosis	1.97e-05	0.000334	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GAPDH—osteoporosis	1.94e-05	0.000329	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.91e-05	0.000324	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.89e-05	0.000321	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—RAP1A—osteoporosis	1.89e-05	0.000321	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PNP—osteoporosis	1.88e-05	0.00032	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ATIC—osteoporosis	1.88e-05	0.00032	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TPI1—osteoporosis	1.88e-05	0.000318	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.86e-05	0.000315	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.85e-05	0.000314	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ACP5—osteoporosis	1.84e-05	0.000312	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TPI1—osteoporosis	1.83e-05	0.000311	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.82e-05	0.000308	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—P4HB—osteoporosis	1.76e-05	0.000299	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ENO1—osteoporosis	1.76e-05	0.000299	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSMA2—osteoporosis	1.74e-05	0.000295	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSMA5—osteoporosis	1.74e-05	0.000295	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GAPDH—osteoporosis	1.73e-05	0.000294	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—P4HB—osteoporosis	1.72e-05	0.000292	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—IDH2—osteoporosis	1.72e-05	0.000292	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TPI1—osteoporosis	1.71e-05	0.00029	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GAPDH—osteoporosis	1.69e-05	0.000287	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RAP1A—osteoporosis	1.69e-05	0.000286	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.65e-05	0.00028	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RAP1A—osteoporosis	1.65e-05	0.000279	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.62e-05	0.000274	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—P4HB—osteoporosis	1.61e-05	0.000273	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ADCY5—osteoporosis	1.61e-05	0.000273	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GPX1—osteoporosis	1.6e-05	0.000272	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA2—osteoporosis	1.6e-05	0.000272	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—OXCT1—osteoporosis	1.6e-05	0.000272	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GAPDH—osteoporosis	1.58e-05	0.000268	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ACP5—osteoporosis	1.57e-05	0.000267	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MGLL—osteoporosis	1.56e-05	0.000265	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.55e-05	0.000263	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RAP1A—osteoporosis	1.54e-05	0.000261	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ENO1—osteoporosis	1.53e-05	0.000259	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSMA5—osteoporosis	1.5e-05	0.000255	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSMA2—osteoporosis	1.5e-05	0.000255	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—osteoporosis	1.48e-05	0.000251	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.47e-05	0.00025	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TPI1—osteoporosis	1.46e-05	0.000248	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.41e-05	0.000239	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—P4HB—osteoporosis	1.37e-05	0.000233	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ENO1—osteoporosis	1.36e-05	0.000231	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000229	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSMA2—osteoporosis	1.34e-05	0.000228	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSMA5—osteoporosis	1.34e-05	0.000228	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.34e-05	0.000228	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ENO1—osteoporosis	1.33e-05	0.000226	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—IDH2—osteoporosis	1.33e-05	0.000225	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RAP1A—osteoporosis	1.31e-05	0.000223	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSMA5—osteoporosis	1.31e-05	0.000223	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSMA2—osteoporosis	1.31e-05	0.000223	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000212	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ENO1—osteoporosis	1.24e-05	0.000211	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000208	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000208	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000207	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ACP5—osteoporosis	1.21e-05	0.000206	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—POMC—osteoporosis	1.18e-05	0.000201	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ADCY5—osteoporosis	1.15e-05	0.000195	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—osteoporosis	1.15e-05	0.000195	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	0.000194	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TPI1—osteoporosis	1.13e-05	0.000191	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.09e-05	0.000185	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO1—osteoporosis	1.06e-05	0.00018	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—P4HB—osteoporosis	1.06e-05	0.00018	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—osteoporosis	1.06e-05	0.00018	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000178	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000178	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GAPDH—osteoporosis	1.04e-05	0.000177	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RAP1A—osteoporosis	1.01e-05	0.000172	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ADCY5—osteoporosis	9.97e-06	0.000169	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—osteoporosis	9.94e-06	0.000169	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.93e-06	0.000169	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—osteoporosis	9.17e-06	0.000156	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADCY5—osteoporosis	8.9e-06	0.000151	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—osteoporosis	8.87e-06	0.000151	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADCY5—osteoporosis	8.69e-06	0.000147	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—osteoporosis	8.66e-06	0.000147	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.49e-06	0.000144	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—POMC—osteoporosis	8.47e-06	0.000144	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO1—osteoporosis	8.2e-06	0.000139	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—osteoporosis	8.19e-06	0.000139	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADCY5—osteoporosis	8.12e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—osteoporosis	8.09e-06	0.000137	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMA2—osteoporosis	8.08e-06	0.000137	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMA5—osteoporosis	8.08e-06	0.000137	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—osteoporosis	7.99e-06	0.000136	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—osteoporosis	7.47e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—POMC—osteoporosis	7.34e-06	0.000125	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADCY5—osteoporosis	6.94e-06	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—osteoporosis	6.91e-06	0.000117	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.55e-06	0.000111	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—POMC—osteoporosis	6.55e-06	0.000111	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—POMC—osteoporosis	6.39e-06	0.000108	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—osteoporosis	6.38e-06	0.000108	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—POMC—osteoporosis	5.97e-06	0.000101	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADCY5—osteoporosis	5.35e-06	9.09e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—osteoporosis	5.34e-06	9.06e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—POMC—osteoporosis	5.1e-06	8.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—osteoporosis	4.92e-06	8.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—POMC—osteoporosis	3.94e-06	6.68e-05	CbGpPWpGaD
